GIRK2 expression in dopamine neurons of the substantia nigra and ventral tegmental area

Journal of Comparative Neurology

Volumn 520, Issue 12, 2012, Pages 2591-2607

  Reyes, Stefanie ^a   Fu, Yuhong ^a   Double, Kay ^a   Thompson, Lachlan ^b   Kirik, Deniz ^c   Paxinos, George ^a   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c LUND UNIVERSITY   (Sweden)

Author keywords

GIRK2; Human; Mouse; Substantia nigra

Indexed keywords

CALBINDIN; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; G PROTEIN REGULATED INWARD RECTIFIER POTASSIUM CHANNEL 2; NEUROMELANIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROPHOTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

AGED, 80 AND OVER; ANIMALS; BRAIN CHEMISTRY; DOPAMINERGIC NEURONS; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; MALE; MICE; MICE, INBRED C57BL; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 84862118786     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23051     Document Type: Article

References (58)

1. Aron L, Klein P, Pham TT, Kramer ER, Wurst W, Klein R. 2010. Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons. PLoS Biol 8: e1000349.
2. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. 1973. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20: 415-455.
3. Braak H, Braak E. 1986. Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. Hum Neurobiol 5: 71-82.
4. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. 2003. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211.
5. Chung CY, Seo H, Sonntag KC, Brooks A, Lin L, Isacson O. 2005. Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet 14: 1709-1725.
6. Collier TJ, Kanaan NM, Kordower JH. 2011. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nat Rev Neurosci 12: 359-366.
7. Corvaja N, Doucet G, Bolam JP. 1993. Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience 55: 417-427.
8. Damier P, Hirsch EC, Agid Y, Graybiel AM. 1999. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain 122: 1421-1436.
9. Double KL, Reyes S, Werry EL, Halliday GM. 2010. Selective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions? Prog Neurobiol 92: 316-329.
10. Duke DC, Moran LB, Pearce RK, Graeber MB. 2007. The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability. Neurogenetics 8: 83-94.
11. Eulitz D, Pruss H, Derst C, Veh RW. 2007. Heterogeneous distribution of kir3 potassium channel proteins within dopaminergic neurons in the mesencephalon of the rat brain. Cell Mol Neurobiol 27: 285-302.
12. Fahn S, Libsch LR, Cutler RW. 1971. Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor. J Neurol Sci 14: 427-455.
13. Fearnley JM, Lees AJ. 1991. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114: 2283-2301.
14. Foehring RC, Zhang XF, Lee JC, Callaway JC. 2009. Endogenous calcium buffering capacity of substantia nigral dopamine neurons. J Neurophysiol 102: 2326-2333.
15. Franklin K, Paxinos G. 2008. The mouse brain in stereotaxic coordinates. San Diego: Elsevier Academic Press.
16. Gibb WR, Lees AJ. 1991. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J Neurol Neurosurg Psychiatry 54: 388-396.
17. Graybiel AM, Ohta K, Roffler-Tarlov S. 1990. Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments. J Neurosci 10: 720-733.
18. Greene JG, Dingledine R, Greenamyre JT. 2005. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol Dis 18: 19-31.
19. Greenfield JG, Bosanquet FD. 1953. The brain-stem lesions in Parkinsonism. J Neurol Neurosurg Psychiatry 16: 213-226.
20. Grimm J, Mueller A, Hefti F, Rosenthal A. 2004. Molecular basis for catecholaminergic neuron diversity. Proc Natl Acad Sci U S A 101: 13891-13896.
21. Halliday GM, McRitchie DA, Cartwright H, Pamphlett R, Hely MA, Morris JG. 1996. Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J Clin Neurosci 3: 52-60.
22. Halliday GM, Ophof A, Broe M, Jensen PH, Kettle E, Fedorow H, Cartwright MI, Griffiths FM, Shepherd CE, Double KL. 2005. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease. Brain 128: 2654-2664.
23. Hardman CD, Henderson JM, Finkelstein DI, Horne MK, Paxinos G, Halliday GM. 2002. Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei. J Comp Neurol 445: 238-255.
24. Hassler R. 1938. Zur Pathologie der Paralysis agitains und des postenzephalitischen Parkinsonismus. J Psychol Neurol 48: 387-476.
25. Herve D, Pickel VM, Joh TH, Beaudet A. 1987. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain research 435: 71-83.
26. Hirsch E, Graybiel A, Agid Y. 1989. Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease. Acta Neurol Scand 126: 19-22.
27. Hopwood SE, Stamford JA. 2001. Multiple 5-HT(1) autoreceptor subtypes govern serotonin release in dorsal and median raphe nuclei. Neuropharmacology 40: 508-519.
28. Kalivas PW. 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18: 75-113.
29. Karschin C, Dissmann E, Stuhmer W, Karschin A. 1996. IRK(1-3) and GIRK(1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain. J Neurosci 16: 3559-3570.
30. Kofuji P, Hofer M, Millen KJ, Millonig JH, Davidson N, Lester HA, Hatten ME. 1996. Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells. Neuron 16: 941-952.
31. Lacey MG, Mercuri NB, North RA. 1987. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol 392: 397-416.
32. Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J. 2008. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57: 760-773.
33. Liang CL, Sinton CM, German DC. 1996a. Midbrain dopaminergic neurons in the mouse: co-localization with calbindin-D28K and calretinin. Neuroscience 75: 523-533.
34. Liang CL, Sinton CM, Sonsalla PK, German DC. 1996b. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 5: 313-318.
35. Liao YJ, Jan YN, Jan LY. 1996. Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J Neurosci 16: 7137-7150.
36. Liss B, Neu A, Roeper J. 1999. The weaver mouse gain-of-function phenotype of dopaminergic midbrain neurons is determined by coactivation of wvGirk2 and K-ATP channels. J Neurosci 19: 8839-8848.
37. Liss B, Haeckel O, Wildmann J, Miki T, Seino S, Roeper J. 2005. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8: 1742-1751.
38. Mackay AV, Yates CM, Wright A, Hamilton P, Davies P. 1978. Regional distribution of monoamines and their metabolites in the human brain. J Neurochem 30: 841-848.
39. McRitchie DA, Halliday GM. 1995. Calbindin D28k-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience 65: 87-91.
40. McRitchie DA, Hardman CD, Halliday GM. 1996. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans. J Comp Neurol 364: 121-150.
41. McRitchie DA, Cartwright HR, Halliday GM. 1997. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease. Exp Neurol 144: 202-213.
42. Mendez I, Sanchez-Pernaute R, Cooper O, Vinuela A, Ferrari D, Bjorklund L, Dagher A, Isacson O. 2005. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 128: 1498-1510.
43. Moukhles H, Bosler O, Bolam JP, Vallee A, Umbriaco D, Geffard M, Doucet G. 1997. Quantitative and morphometric data indicate precise cellular interactions between serotonin terminals and postsynaptic targets in rat substantia nigra. Neuroscience 76: 1159-1171.
44. Murer G, Adelbrecht C, Lauritzen I, Lesage F, Lazdunski M, Agid Y, Raisman-Vozari R. 1997. An immunocytochemical study on the distribution of two G-protein-gated inward rectifier potassium channels (GIRK2 and GIRK4) in the adult rat brain. Neuroscience 80: 345-357.
45. Navarro B, Kennedy ME, Velimirovic B, Bhat D, Peterson AS, Clapham DE. 1996. Nonselective and G betagamma-insensitive weaver K+ channels. Science 272: 1950-1953.
46. Paxinos G, Huang X. 1995. Atlas of the human brainstem. San Diego, CA: Academic Press.
47. Penington NJ, Kelly JS, Fox AP. 1993. Whole-cell recordings of inwardly rectifying K+ currents activated by 5-HT1A receptors on dorsal raphe neurones of the adult rat. J Physiol 469: 387-405.
48. Poirier LJ, Giguere M, Marchand R. 1983. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat. Brain Res Bull 11: 371-397.
49. Saenz del Burgo L, Cortes R, Mengod G, Zarate J, Echevarria E, Salles J. 2008. Distribution and neurochemical characterization of neurons expressing GIRK channels in the rat brain. J Comp Neurol 510: 581-606.
50. Schein JC, Hunter DD, Roffler-Tarlov S. 1998. Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. Dev Biol 204: 432-450.
51. Slesinger PA, Patil N, Liao YJ, Jan YN, Jan LY, Cox DR. 1996. Functional effects of the mouse weaver mutation on G protein-gated inwardly rectifying K+ channels. Neuron 16: 321-331.
52. Stromberg I, Bickford P, Gerhardt GA. 2010. Grafted dopamine neurons: morphology, neurochemistry, and electrophysiology. Prog Neurobiol 90: 190-197.
53. Surmeier DJ, Guzman JN, Sanchez-Padilla J, Goldberg JA. 2010. What causes the death of dopaminergic neurons in Parkinson's disease? Prog Brain Res 183: 59-77.
54. Thompson L, Barraud P, Andersson E, Kirik D, Bjorklund A. 2005. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J Neurosci 25: 6467-6477.
55. van der Kooy D, Hattori T. 1980. Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat. Brain Res 186: 1-7.
56. Wickman K, Clapham DE. 1995. Ion channel regulation by G proteins. Physiol Rev 75: 865-885.
57. Wirtshafter D, Stratford TR, Asin KE. 1987. Evidence that serotonergic projections to the substantia nigra in the rat arise in the dorsal, but not the median, raphe nucleus. Neurosci Lett 77: 261-266.
58. Yamada T, McGeer PL, Baimbridge KG, McGeer EG. 1990. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res 526: 303-307.